Related Experiment Video
Updated: Jul 4, 2026
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Identification of novel genes involved in the synergistic antitumor effect of caffeine in osteosarcoma cells using
Sadao Ii1, Yoshimichi Ueda, Miyako Shimazaki
1Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
Background:
Caffeine enhances the cytocidal effects of DNA-damaging agents. This study investigated genes involved in the synergistic effect of caffeine on osteosarcoma cells using gene-profiling analysis.
Materials And Methods:
Sensitivity to cisplatin and the synergistic effect of caffeine were evaluated in five osteosarcoma cell lines with different p53 gene status. Gene expression profiles were analyzed using cDNA macroarray and verified by real-time RT-PCR.
Results:
The cell lines were grouped into three types with different cytotoxic patterns. Comparison of profiling data from these groups identified twelve novel genes associated with the synergistic effect of caffeine. Real-time RT-PCR analyses verified up-regulation of two apoptosis-enhancing genes and down-regulation of two interferon-inducible genes related to the synergy of caffeine.
Conclusion:
These findings provide new insights into the molecular mechanisms of the synergistic effect of caffeine related to p53 gene status in osteosarcoma, providing candidates for an assay of responsiveness to caffeine-potentiated chemotherapy for osteosarcoma.
Insights
Caffeine enhances chemotherapy for osteosarcoma by affecting gene expression. This study identified novel genes linked to caffeine
Area of Science:
- Molecular biology
- Cancer research
- Pharmacology
Background:
- Caffeine is known to potentiate the effects of DNA-damaging chemotherapy agents.
- The molecular mechanisms underlying caffeine's synergy in osteosarcoma remain largely unexplored.
Purpose of the Study:
- To investigate the genes involved in the synergistic effect of caffeine on osteosarcoma cells.
- To analyze the influence of p53 gene status on caffeine's chemosensitizing properties.
Main Methods:
- Evaluated sensitivity to cisplatin and caffeine synergy in five osteosarcoma cell lines with varying p53 gene status.
- Utilized cDNA macroarray for gene expression profiling and real-time RT-PCR for verification.
Main Results:
- Identified twelve novel genes associated with caffeine's synergistic effect.
- Observed differential gene expression patterns, including up-regulation of apoptosis-enhancing genes and down-regulation of interferon-inducible genes.
- Correlated cytotoxic patterns with p53 gene status.
Conclusions:
- Elucidated molecular mechanisms of caffeine synergy in osteosarcoma, highlighting the role of p53.
- Identified potential candidate genes for predicting responsiveness to caffeine-potentiated chemotherapy in osteosarcoma patients.
